A 2-month-old male neonate presents with lethargy, poor feeding, and hyperammonemia (ammonia 250 µmol/L). Plasma amino acid analysis shows elevated glutamine and alanine but low citrulline and arginine. Urine orotic acid is normal. A second patient, age 5 years, has recurrent hyperammonemic crises triggered by infection, with similar amino acid profile but markedly elevated urinary orotic acid. Which laboratory finding best distinguishes carbamoyl phosphate synthetase I (CPS I) deficiency from ornithine transcarbamylase (OTC) deficiency in these two patients?

Explanation

## Distinguishing CPS I from OTC Deficiency: Urinary Orotic Acid as the Gold Standard ### Overview Both CPS I deficiency and OTC deficiency cause hyperammonemia with low citrulline and arginine, making clinical and biochemical profiles superficially similar. However, **urinary orotic acid excretion** is the single most reliable discriminator. ### Pathophysiology of Orotic Acid Elevation ```mermaid flowchart TD A[Carbamoyl Phosphate Synthetase I]:::action --> B{Carbamoyl Phosphate Produced?}:::decision B -->|Yes: CPS I normal| C[Substrate for OTC]:::outcome C --> D{OTC Functional?}:::decision D -->|No: OTC deficiency| E[Carbamoyl phosphate accumulates]:::outcome E --> F[Shunted to pyrimidine synthesis]:::action F --> G[Orotic acid ↑↑↑]:::urgent B -->|No: CPS I deficiency| H[No carbamoyl phosphate]:::outcome H --> I[Pyrimidine synthesis normal]:::action I --> J[Orotic acid normal]:::outcome ``` ### Biochemical Mechanism **Key Point:** In OTC deficiency, carbamoyl phosphate (produced normally by CPS I) accumulates and is diverted into the pyrimidine biosynthetic pathway, resulting in massive orotic acid production and urinary excretion. In CPS I deficiency, carbamoyl phosphate is never formed, so there is no substrate to be shunted into pyrimidine synthesis — urinary orotic acid remains normal. ### Comparison Table | Parameter | CPS I Deficiency | OTC Deficiency | | --- | --- | --- | | **Urinary orotic acid** | **Normal** | **Markedly elevated (>1000× normal)** | | **Plasma ammonia** | ↑↑↑ | ↑↑↑ | | **Plasma citrulline** | Low/absent | Low/absent | | **Plasma arginine** | Low/absent | Low/absent | | **Plasma glutamine** | ↑↑ | ↑↑ | | **Inheritance** | Autosomal recessive | X-linked | | **Neonatal presentation** | Both sexes | Males (hemizygous) | ### High-Yield Fact **High-Yield:** Orotic acid crystalluria (orange crystals in urine) is a classic and sometimes visible sign of OTC deficiency. A simple urine dipstick or crystal examination can provide a diagnostic clue at the bedside. ### Why This Discriminates **Clinical Pearl:** Even though both patients present with hyperammonemia and low citrulline/arginine, the urinary orotic acid level immediately identifies the enzymatic defect: - **Normal orotic acid** → CPS I deficiency (block at step 1) - **Elevated orotic acid** → OTC deficiency (block at step 2, with backup into pyrimidine pathway) ### Mnemonic **Mnemonic:** **OTC = Orotic acid Tremendously elevated in Carbamoyl phosphate accumulation** Remember: The enzyme that fails determines where carbamoyl phosphate goes. If OTC fails, it backs up and feeds pyrimidine synthesis → orotic acid overproduction. [cite:Lehninger Principles of Biochemistry 8e Ch 23; Harrison 21e Ch 387]